Michael Shawn Moran - 05 Jan 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
EVP, Chief Commercial Officer
Signature
/s/ Brian Cahill, Attorney-in-Fact
Issuer symbol
EGRX
Transactions as of
05 Jan 2022
Net transactions value
-$76,593
Form type
4
Filing time
07 Jan 2022, 15:39:00 UTC
Previous filing
07 Oct 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability $76,593 -1,511 -6.2% $50.69 22,757 05 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations.